+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 66 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 5822921
The Medical Devices sector report, “Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Cortical Stimulators pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The cortical stimulator is a medical device used to revive neural activity in the nervous system of critical patients by delivering an electrical shock using leads and electrode arrays implanted on the surface of the brain to induce brain activity.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cortical Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cortical Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cortical Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cortical Stimulators Overview
3 Products under Development
3.1 Cortical Stimulators - Pipeline Products by Stage of Development
3.2 Cortical Stimulators - Pipeline Products by Territory
3.3 Cortical Stimulators - Pipeline Products by Regulatory Path
3.4 Cortical Stimulators - Pipeline Products by Estimated Approval Date
3.5 Cortical Stimulators - Ongoing Clinical Trials
4 Cortical Stimulators - Pipeline Products under Development by Companies
4.1 Cortical Stimulators Companies - Pipeline Products by Stage of Development
4.2 Cortical Stimulators - Pipeline Products by Stage of Development
5 Cortical Stimulators Companies and Product Overview
5.1 ab medica spa Company Overview
5.1.1 ab medica spa Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aleva Neurotherapeutics SA Company Overview
5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cadence Neuroscience Inc Company Overview
5.3.1 Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Catalan Institute of Nanoscience and Nanotechnology Company Overview
5.4.1 Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview
5.5 Clinatec Company Overview
5.5.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
5.6 Columbia Engineering Company Overview
5.6.1 Columbia Engineering Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cortigent Inc Company Overview
5.7.1 Cortigent Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cortivis Company Overview
5.8.1 Cortivis Pipeline Products & Ongoing Clinical Trials Overview
5.9 EPIC Neuro Inc Company Overview
5.9.1 EPIC Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Hangzhou Jialiang Medical Technology Co Ltd Company Overview
5.10.1 Hangzhou Jialiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Johns Hopkins University Company Overview
5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Koninklijke Philips NV Company Overview
5.12.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medtronic Company Overview
5.13.1 Medtronic Pipeline Products & Ongoing Clinical Trials Overview
5.14 NeuroPace Inc Company Overview
5.14.1 NeuroPace Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 NYU Langone Health System Company Overview
5.15.1 NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview
5.16 Polytechnique Montreal Company Overview
5.16.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview
5.17 Precisis GmbH Company Overview
5.17.1 Precisis GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.18 St. Jude Medical LLC Company Overview
5.18.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of California Los Angeles Company Overview
5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Wisconsin Madison Company Overview
5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
5.21 WISE s.r.l. Company Overview
5.21.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
6 Cortical Stimulators- Recent Developments
6.1 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
6.2 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
6.3 Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
6.4 Dec 21, 2023: NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
6.5 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
6.6 Oct 16, 2023: EASEE: The Innovation in Epilepsy Treatment - The Groundbreaking Implant in the Spotlight of Medtech Outlook
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Cortical Stimulators - Pipeline Products by Stage of Development
  • Cortical Stimulators - Pipeline Products by Territory
  • Cortical Stimulators - Pipeline Products by Regulatory Path
  • Cortical Stimulators - Pipeline Products by Estimated Approval Date
  • Cortical Stimulators - Ongoing Clinical Trials
  • Cortical Stimulators Companies - Pipeline Products by Stage of Development
  • Cortical Stimulators - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Cortical Stimulators - Pipeline Products by Stage of Development
  • Cortical Stimulators - Pipeline Products by Territory
  • Cortical Stimulators - Pipeline Products by Regulatory Path
  • Cortical Stimulators - Pipeline Products by Estimated Approval Date
  • Cortical Stimulators - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ab medica spa
  • Aleva Neurotherapeutics SA
  • Cadence Neuroscience Inc
  • Catalan Institute of Nanoscience and Nanotechnology
  • Clinatec
  • Columbia Engineering
  • Cortigent Inc
  • Cortivis
  • EPIC Neuro Inc
  • Hangzhou Jialiang Medical Technology Co Ltd
  • Johns Hopkins University
  • Koninklijke Philips NV
  • Medtronic
  • NeuroPace Inc
  • NYU Langone Health System
  • Polytechnique Montreal
  • Precisis GmbH
  • St. Jude Medical LLC
  • University of California Los Angeles
  • University of Wisconsin Madison
  • WISE s.r.l.